home · filing · 0000950170-22-006366
8-K filed April 27, 2022, 7:59 PM ET
ticker ERAS
CIK 0001761918
leadership
confidence high
sentiment neutral
materiality 0.55
Erasca appoints Jean Liu to Board of Directors, increases board size to nine
Erasca, Inc.
Board expanded to nine members, appointed Jean Liu as Class III director until 2024 annual meeting.
Liu is Chief Legal Officer and Corporate Secretary of Seagen Inc., a global biotechnology company.
Received options to purchase 80,000 shares of common stock, vesting monthly over three years.
Liu appointed to Audit Committee, joining Casdin, Chen, and Hambleton.
Board determined Liu is independent under Nasdaq listing standards.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Jean Liu
Director
Effective 2022-04-25
Filed April 27, 2022, 7:59 PM ET
the Board appointed Jean Liu, J.D., to fill such newly created directorship.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Jean Liu was appointed as Director at Erasca, Inc..
Action appointed
Role Director
Exact text from the filing
the Board appointed Jean Liu, J.D., to fill such newly created directorship.
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-22-006366
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.